Chronomics’ solution to scale mass testing for COVID-19
While we wait for a COVID-19 vaccine to be ready (which won’t likely happen for the next 12-18 months), we need to get prepared for what some people have called the ‘new normal’. This novel model of society, with different rules of behaviour and social organisation, will include different degrees of social distancing, contact tracing and disease monitoring at population scale. And this ‘new normal’ could be in place until as late as 2024.
A fundamental pillar of the post-lockdown world and the back-to-work strategy is the ability to implement mass testing for COVID-19. Most countries are currently lagging behind when it comes to scaling testing capacity. There are also questions about how this strategy could be successfully implemented at population scale and maintained for a long period of time. At Chronomics, we want to contribute to solving this problem and we have developed a COVID-19 saliva testing kit that has the characteristics required for mass testing:
We are making this test available for consumers, companies, hospitals, laboratories and governments around the globe that want to contribute to make the ‘new normal’ a better place to live in.
Dr. Daniel E. Martin-Herranz is the CSO and co-founder at Chronomics
Have a podcast? Speak to us about one of our epigenetics experts appearing as a guest.
Coronavirus testing kit
Accurately test for COVID-19 without an invasive swab or medical staff.
Identify risk of chronic illness and measure the success of your treatments using Epigenetics.